The company is attempting to lower its $30 billion in accrued debts.
Here is what you need to know.
1. Valeant shares closed Jan. 9, 2017 at $15.35 and opened the following day at $17.12 following the acquisition news.
2. The company ended its day at $16.42. As of 11 a.m. EST, Jan. 11, 2017, Valeant was trading at $16.26.
3. Valeant’s 52-week range is between $13 and $101.40.
4. The company has a market cap of $5.93 billion.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Bradley Zins of the Billings Clinic
ASGE certifies Mercy Hospital: 3 things to know
Dr. Brian Davis hosts video on The Fundamentals of Endoscopic Surgery exam
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.